HCW Biologics Inc [HCWB] stock is trading at $10.05, up 92.90%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HCWB shares have gain 50.45% over the last week, with a monthly amount glided 9.48%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
HCW Biologics Inc [HCWB] stock has fluctuated between $5.00 and $100.80 over the past year. HCW Biologics Inc [NASDAQ: HCWB] shares were valued at $10.05 at the most recent close of the market.
Analyzing the HCWB fundamentals
HCW Biologics Inc [NASDAQ:HCWB] reported sales of 2.57M for the trailing twelve months, which represents a drop of -70.18%. Gross Profit Margin for this corporation currently stands at 0.28% with Operating Profit Margin at -11.49%, Pretax Profit Margin comes in at -11.7%, and Net Profit Margin reading is -11.7%. To continue investigating profitability, this company’s Return on Assets is posted at -0.99, Equity is 8.4 and Total Capital is -48.51. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-2.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.25 points at the first support level, and at 2.44 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.83, and for the 2nd resistance point, it is at 21.60.
Ratios To Look Out For
For context, HCW Biologics Inc’s Current Ratio is 0.19. As well, the Quick Ratio is 0.19, while the Cash Ratio is 0.16. Considering the valuation of this stock, the price to sales ratio is 4.39.
Transactions by insiders
Recent insider trading involved Winer Gary M, Director, that happened on May 08 ’25 when 2308.0 shares were purchased. Chief Executive Officer, Wong Hing C completed a deal on May 08 ’25 to buy 92500.0 shares. Meanwhile, Director GARRETT SCOTT T bought 5385.0 shares on May 08 ’25.
